The development of marijuana dispensaries for recreational use may nullify the potential benefits of medical marijuana. How can medical practitioners and dispensaries ensure the continued usefulness of medicinal marijuana in a post-legalization society? Connect with medical marijuana doctors at the HappyMD website.
With 18 states and the District of Columbia planning to allow recreational marijuana usage by 2021, the legalization of marijuana as a recreational substance has become a political hot potato. Both New Jersey and Connecticut intend to open recreational marijuana stores in 2022; New Jersey's opening date is April 21, 2022.
As a consequence of the 37 states (including the aforementioned 18) that have legalized medical marijuana, the existing systems of medical marijuana prescription and distribution are expected to change. What measures can medical experts, dispensary owners, and patients do to guarantee that medicinal marijuana's usefulness as a painkiller does not diminish while recreational use increases?
The market for medicinal marijuana is substantial.
Now that both varieties of marijuana are more publicly accessible, it is essential to comprehend their differences. THC4 is the sole active component in marijuana used for recreational purposes. THC binds to cannabinoid receptors in the brain, which govern, among other activities, pain perception and mood. Numerous medical diseases, including multiple sclerosis, nerve pain, Parkinson's disease, and nausea, react well to medicinal marijuana containing THC. CBD, or cannabidiol, is used to treat a range of medical ailments, including Crohn's disease, anxiety, arthritis, diabetes, and insomnia. However, there is little evidence that CBD helps in any of these conditions.
According to Dr. Gregory Carter, M.D., M.S., a physician at the Providence Medicinal Center, the primary contrast between medical and recreational use is the desired outcome and method of ingestion. "Medical users seek medical relief and would presumably consume edibles, while recreational users often smoke with the intent of getting high"
As of 2021, around 5.55 million Americans have registered for medical marijuana use in 37 states, and registration is necessary before a prescription may be given or used. Due to the fact that certain states have not yet legalized marijuana in any form, not all Americans can benefit from medical marijuana.
According to Mitchell Prywes, MD, medical director of the Center for Pain Rehabilitation, marijuana is superior to opiates as a pain medication since it lacks a catastrophic overdose risk.
According to him, the endocannabinoid6 system, which is common in mammals and equivalent to the cannabinoid system, synthesizes cannabinoid-like substances that activate receptors to maintain homeostasis in the body, similar to the effects of medical marijuana.
Despite the need for more research, this association suggests that marijuana may be effective in treating a broad variety of medical conditions. However, if more states legalize cannabis for recreational use, the influence of medical marijuana may decline.
The Medical Marijuana Industry: Is Recreational Use a Threat?
Colorado and Washington were the first two U.S. states to legalize marijuana in its entirety in 2012. In 1996, the state of California approved the substance for therapeutic reasons. 35 states have followed Colorado and Washington in legalizing recreational marijuana in less than a decade. Voters in South Dakota, New Jersey, Arizona, and Montana legalized recreational marijuana use as recently as 2020.
According to Dr. Jordan Tishler, chief executive officer of Inhale MD and founder of the Association of Cannabinoid Specialists, this new growth in the recreational marijuana market has affected the medical marijuana industry.
The objective of the industry is to eliminate the need for physician monitoring by classifying everyone as a casual user. According to him, their motivation was to maximize earnings from marijuana sales. Their technique increases earnings, but also tolerance levels and the possibility for cannabis dependency to develop in the future.
According to Tishler, many recreational marijuana users develop symptoms that may be alleviated by medical marijuana. Now that marijuana use is legal for recreational purposes, he claims, more individuals are building tolerance to the substance, rendering medical marijuana ineffectual for them.
WebMD8 says that a three-week break from cannabis use may help lessen tolerance. However, this is not always feasible and may present problems for those who use marijuana regularly for medical reasons.
According to Tishler, several establishments (both medical and recreational) provide improper medical advice in an attempt to increase sales. What disturbs him the most is seeing a patient who "was cannabis-naive six to twelve months ago" but has now fallen behind in life owing to self-medicating for recreational purposes.
Due to the legalization of marijuana for recreational use, the effort to establish medical marijuana as an accepted therapeutic choice for all ages has encountered a new challenge. It may be essential to develop a way for the two kinds of dispensaries to collaborate and coexist for the benefit of patient health.
What is involved in collaborative work?
How can dispensaries serving both medical and recreational users limit the danger of overconsumption and tolerance development among their customers?
Tishler suggests a marijuana distribution system modeled like pharmacies. He said that physicians should be "authorized and required to give a legitimate prescription" and that dispensaries should "respect the prescription as written."
When recreational shops open in Connecticut later this year, nine pharmacists will be present in hybrid and medical facilities.
We were one of the first states to embrace a pharmaceutical approach, according to Prywes. This implies that all four of the state's manufacturers must comply to severe quality standards and operate similarly to pharmaceutical companies. Similarly, "all dispensaries are comparable to pharmacies and are required to employ licensed, certified pharmacists."
By adopting this measure, governments may ensure that the wellness of their population is a top priority. This requirement is not ubiquitous, though. Before deciding on dosage or other therapies, it is essential for patients to consult with physicians who are knowledgeable in medical marijuana.
"A true doctor-patient relationship is crucial," stated Prywes.
An established doctor-patient relationship requires a comprehensive grasp of the patient's medical history, including what the patient has and has not encountered....
This is not a generic postage stamp. As a consequence of these open dialogues, he said, those with a history of drug or substance abuse may be precluded from getting medical marijuana.
Tishler said that physicians should be in charge of medical marijuana, but that patients and physicians may have open, nonjudgmental conversations about marijuana use to help with medication review.
"Primary care providers must begin proactively prescribing cannabis to their patients rather than opting for more dangerous [such as opioids] or less effective [such as gabapentinoids] alternatives....
"In order for our patients to obtain the necessary care, we must begin volunteering," he remarked.
Similar to referring a patient to a cardiologist or dermatologist, he recommended that practitioners refer patients to cannabis specialists to ensure they get the right cannabinoid medication.
Because it is so easy to use marijuana for medical or recreational reasons, some individuals may consume excessive amounts. It is thus essential that patients have access to the therapy they need, while also preventing drug abuse.